ArticleBlood cancer journal2025
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.
Abstract readLetter
In one paragraph
Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.Annals of hematology · 2026Article
- Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.Blood cancer journal · 2025Article
- Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment.Leukemia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
47 authors.
Christina RautenbergDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany.
Jan Moritz MiddekeMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0003-3250-293X
Christoph RölligMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-3791-0548
Matthias StelljesDepartment of Medicine A, University Hospital Münster, Münster, Germany.ORCID http://orcid.org/0000-0002-9331-5145
Verena GaidzikDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0001-6530-3406
Oliver KriegeDepartment of Medicine III, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Mareike VerbeekDepartment of Medicine III, Technical University of Munich, Munich, Germany.
Katrin KochDepartment of Medicine III, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-4664-8016
Julia Marie UnglaubDepartment of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
Felicitas TholDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-5848-6152
Stefan W KrauseDepartment 5 for Internal Medicine, University Hospital Erlangen, Erlangen, Germany.ORCID http://orcid.org/0000-0002-5259-4651
Mathias HänelDepartment of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany.
Charlotte NeuerburgDepartment of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0009-0009-3134-9567
Vladan VucinicDepartment of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany.ORCID http://orcid.org/0000-0002-8398-285X
Christian-Friedrich JehnDepartment of Hematology, Oncology and Stem Cell Transplantation, Asklepios Clinic St. Georg, Hamburg, Germany.
Maxi WassDepartment of Hematology, Oncology and Stem Cell Transplantation, Asklepios Clinic St. Georg, Hamburg, Germany.
Michael HeuserDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-5318-9044
Lars FranseckyDivision of Stem Cell Transplantation and Cellular Imunotherapies, Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
Jens ChemnitzGemeinschaftsklinikum Mittelrhein GGmbH, Koblenz, Germany.
Udo HoltickDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Kerstin Schäfer-EckartDepartment of Internal Medicine V, Oncology and Hematology, Klinikum Nürnberg, Nürnberg, Germany.
Josephine SchröderClinic for Hematology and Stem Cell Transplantation HELIOS Clinic Berlin-Buch GmbH, Berlin, Germany.
Sabrina KrausDivision of Hematology and Oncology, Department of Internal Medicine II, University of Würzburg, Medical Center, Würzburg, Germany.
William KrügerClinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of Greifswald, Greifswald, Germany.
Ulrich KaiserDepartment of Hematology and Oncology, St. Bernward Krankenhaus, Hildesheim, Germany.
Sebastian SchollDepartment of Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany.
Guido KobbeDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf, Germany.ORCID http://orcid.org/0000-0002-9745-8813
Paul Sebastian JägerDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf, Germany.
Nael AlakelMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0003-3669-5564
Malte von BoninMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-3828-0031
Katja SockelMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0003-1732-7299
Maher HanounDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany.ORCID http://orcid.org/0000-0002-1754-8940
Uwe PlatzbeckerDepartment of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany.
Tobias A W HolderriedDepartment of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0002-2474-523X
Anke MorgnerDepartment of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany.
Tim SauerDepartment of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
Katharina S GötzeDepartment of Medicine III, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6276-8002
Eva Wagner-DrouetDepartment of Medicine III, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-0728-2253
Konstanze DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0002-2261-9862
Hartmut DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0003-2116-5536
Christoph SchliemannDepartment of Medicine A, University Hospital Münster, Münster, Germany.ORCID http://orcid.org/0000-0003-1755-9583
Johannes ScheteligMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-2780-2981
Martin BornhäuserMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany.
Ulrich GermingDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf, Germany.
Sara FlossdorfDepartment for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.ORCID http://orcid.org/0000-0003-0642-7104
Thomas Schroeder *Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany. Thomas.schroeder@uk-essen.de.ORCID http://orcid.org/0000-0002-1653-7959
Friedrich Stölzel *Division of Stem Cell Transplantation and Cellular Imunotherapies, Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID http://orcid.org/0000-0003-0653-5332
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.